Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts

Springer Semin Immunopathol. 1998;20(3-4):455-91. doi: 10.1007/BF00838055.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Acute Disease
  • Animals
  • Antigens, Viral / immunology
  • B-Lymphocytes / virology
  • Bone Marrow Transplantation / adverse effects*
  • Cell Transformation, Viral / immunology
  • Epstein-Barr Virus Infections / immunology
  • Epstein-Barr Virus Infections / therapy*
  • Epstein-Barr Virus Infections / virology
  • HLA Antigens
  • Herpesvirus 4, Human / immunology
  • Herpesvirus 4, Human / physiology
  • Humans
  • Immunity, Cellular
  • Immunocompromised Host / immunology
  • Immunotherapy
  • Immunotherapy, Adoptive*
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / therapy*
  • Lymphoproliferative Disorders / virology
  • Rats
  • T-Lymphocytes / virology
  • T-Lymphocytes, Cytotoxic / immunology
  • Transplantation, Homologous
  • Viral Proteins / immunology
  • Virus Latency

Substances

  • Antigens, Viral
  • HLA Antigens
  • Viral Proteins